Arousability in sleep apnoea/hypopnoea syndrome patients.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMID 12358354)

Published in Eur Respir J on September 01, 2002

Authors

K Dingli1, I Fietze, T Assimakopoulos, S Quispe-Bravo, C Witt, N J Douglas

Author Affiliations

1: Respiratory Medicine Unit, University of Edinburgh, UK.

Articles by these authors

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet (2002) 5.48

Transient hypoxaemia during sleep in chronic bronchitis and emphysema. Lancet (1979) 4.85

The sleep hypopnea syndrome. Am Rev Respir Dis (1988) 3.31

The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev (1999) 3.21

Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial. Ann Intern Med (2001) 3.19

[German guideline for diagnosis and management of idiopathic pulmonary fibrosis]. Pneumologie (2013) 3.03

Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med (1999) 2.98

Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep Apnea/Hypopnea syndrome. Am J Respir Crit Care Med (1999) 2.77

Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med (2001) 2.68

Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet (1994) 2.68

Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest (1996) 2.58

Sleep apnoea in heart failure. Eur Respir J (2007) 2.56

Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax (1997) 2.47

Evaluation of a portable device for diagnosing the sleep apnoea/hypopnoea syndrome. Eur Respir J (2003) 2.42

Series of exon-skipping events in the elastic spring region of titin as the structural basis for myofibrillar elastic diversity. Circ Res (2000) 2.39

Non-CPAP therapies in obstructive sleep apnoea. Eur Respir J (2011) 2.36

Acute right-sided heart failure due to hemorrhage into a pericardial cyst. Ann Thorac Surg (1997) 2.24

Accuracy sensitivity to carboxyhemoglobin, and speed of response of the Hewlett-Packard 47201A ear oximeter. Am Rev Respir Dis (1979) 2.17

Factors impairing daytime performance in patients with sleep apnea/hypopnea syndrome. Arch Intern Med (1992) 2.15

Neck soft tissue and fat distribution: comparison between normal men and women by magnetic resonance imaging. Thorax (1999) 2.12

Can intensive support improve continuous positive airway pressure use in patients with the sleep apnea/hypopnea syndrome? Am J Respir Crit Care Med (1999) 2.02

Sleep apnoea: clinical importance and facilities for investigation and treatment in the UK. Addendum to the 1993 Royal College of Physicians Sleep Apnoea report. J R Coll Physicians Lond (1999) 2.01

The effect of nonvisible sleep fragmentation on daytime function. Am J Respir Crit Care Med (1997) 1.98

Sleep. 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome. Thorax (2004) 1.93

I-band titin in cardiac muscle is a three-element molecular spring and is critical for maintaining thin filament structure. J Cell Biol (1999) 1.88

Compliance with CPAP therapy in patients with the sleep apnoea/hypopnoea syndrome. Thorax (1994) 1.85

Uvulopalatopharyngoplasty may compromise nasal CPAP therapy in sleep apnea syndrome. Am J Respir Crit Care Med (1996) 1.84

Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax (1998) 1.77

Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist. BMJ (1990) 1.73

Cognitive function in the sleep apnea/hypopnea syndrome (SAHS). Sleep (2000) 1.66

Irregular breathing and hypoxaemia during sleep in chronic stable asthma. Lancet (1982) 1.65

Hypoxic ventilatory response decreases during sleep in normal men. Am Rev Respir Dis (1982) 1.62

The effect of oxygenation on sleep quality in chronic bronchitis and emphysema. Am Rev Respir Dis (1982) 1.62

Neck and total body fat deposition in nonobese and obese patients with sleep apnea compared with that in control subjects. Am J Respir Crit Care Med (1998) 1.61

Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Tissue Antigens (2003) 1.60

Bronchodilatation and the site of airway resistance in severe chronic bronchitis. Thorax (1979) 1.60

Titin-actin interaction in mouse myocardium: passive tension modulation and its regulation by calcium/S100A1. Biophys J (2001) 1.59

Transient hypoxemia during sleep in chronic obstructive pulmonary disease is not a sleep apnea syndrome. Am Rev Respir Dis (1983) 1.58

Clinical features of the sleep apnoea/hypopnoea syndrome. Q J Med (1989) 1.56

Sleep-disordered breathing after stroke: a randomised controlled trial of continuous positive airway pressure. J Neurol Neurosurg Psychiatry (2006) 1.55

The effect of sleep fragmentation on daytime function. Am J Respir Crit Care Med (1996) 1.55

Pathological assessment of mediastinal lymph nodes in lung cancer: implications for non-invasive mediastinal staging. Thorax (1992) 1.54

Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema; effects on plasma brain natriuretic peptide concentrations. Eur Heart J (2002) 1.52

Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry (2000) 1.52

Under reporting of sleepiness and driving impairment in patients with sleep apnoea/hypopnoea syndrome. J Sleep Res (1997) 1.51

Respiration during sleep in normal man. Thorax (1982) 1.49

Hypercapnic ventilatory response in sleeping adults. Am Rev Respir Dis (1982) 1.48

Evaluation of Biox IIA ear oximeter. Thorax (1985) 1.46

Alcohol and cor pulmonale in chronic bronchitis and emphysema. BMJ (1993) 1.44

Introduction of the lung allocation score in Germany. Am J Transplant (2014) 1.42

An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis. Parasitology (2000) 1.42

Does arousal frequency predict daytime function? Eur Respir J (1998) 1.41

The effect of age, sex, obesity and posture on upper airway size. Eur Respir J (1997) 1.41

Breathing patterns during sleep in patients with nocturnal asthma. Thorax (1987) 1.39

Identification and biochemical characterization of Arabidopsis thaliana sulfite oxidase. A new player in plant sulfur metabolism. J Biol Chem (2001) 1.38

Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids. J Immunol (1997) 1.38

Effect of continuous positive airway pressure on sleep architecture in the sleep apnea-hypopnea syndrome: a randomized controlled trial. Am J Respir Crit Care Med (2001) 1.36

Can psychological factors help us to determine adherence to CPAP? A prospective study. Eur Respir J (2004) 1.36

The effect of posture on upper airway dimensions in normal subjects and in patients with the sleep apnea/hypopnea syndrome. Am Rev Respir Dis (1991) 1.35

Effect of sleep deprivation on overnight bronchoconstriction in nocturnal asthma. Thorax (1986) 1.34

Spectral oscillations of RR intervals in sleep apnoea/hypopnoea syndrome patients. Eur Respir J (2003) 1.33

Comparison of nose and face mask CPAP therapy for sleep apnoea. Thorax (1998) 1.29

Family studies in patients with the sleep apnea-hypopnea syndrome. Ann Intern Med (1995) 1.28

Partners of patients with sleep apnoea/hypopnoea syndrome: effect of CPAP treatment on sleep quality and quality of life. Thorax (2001) 1.27

Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation. Gut (1998) 1.27

Sleep-disordered breathing and upper airway size in pregnancy and post-partum. Eur Respir J (2006) 1.25

Genetic control of suppressor lymphocyte function in myasthenia gravis: relationship of impaired suppressor function to HLA-B8/DRW3 and cold reactive lymphocytotoxic antibodies. Clin Immunol Immunopathol (1979) 1.23

Management of obstructive sleep apnoea/hypopnoea syndrome. Lancet (1994) 1.23

Frequency of EEG arousals from nocturnal sleep in normal subjects. Sleep (1995) 1.23

Sexual influence on the control of breathing. J Appl Physiol Respir Environ Exerc Physiol (1983) 1.22

Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome. Eur Respir J (2005) 1.21

HLA-DRB1 DNA sequencing based typing: an approach suitable for high throughput typing including unrelated bone marrow registry donors. Tissue Antigens (2001) 1.18

Morbidity in nocturnal asthma: sleep quality and daytime cognitive performance. Thorax (1991) 1.18

Fundamentals of pulmonary drug delivery. Respir Med (2003) 1.16

Temporary tracheobronchial stenting in malignant lymphoma. Ann Thorac Surg (1999) 1.15

A bioinformatics approach to ascertaining the rarity of HLA alleles. Tissue Antigens (2009) 1.15

[Prevention, diagnosis, therapy, and follow-up of lung cancer]. Pneumologie (2010) 1.14

Evaluation of a computerised polysomnography system. Thorax (1993) 1.13

Snoring, asthma and sleep disturbance in Britain: a community-based survey. Eur Respir J (1993) 1.12

Pulmonary function following laparoscopic or conventional colorectal resection: a randomized controlled evaluation. Arch Surg (1999) 1.12

Daytime sleepiness, cognitive performance and mood after continuous positive airway pressure for the sleep apnoea/hypopnoea syndrome. Thorax (1993) 1.12

The European Sleep Apnoea Database (ESADA): report from 22 European sleep laboratories. Eur Respir J (2011) 1.11

Night-to-night variation of the oxygen desaturation index in sleep apnoea syndrome. Eur Respir J (2004) 1.11

Sleep deprivation and the control of ventilation. Am Rev Respir Dis (1983) 1.11

Predictors of improvements in daytime function outcomes with CPAP therapy. Am J Respir Crit Care Med (2000) 1.10

Use of home sleep studies for diagnosis of the sleep apnoea/hypopnoea syndrome. Thorax (1997) 1.10

Tongue protrusion strength and fatiguability: relationship to apnoea/hypopnoea index and age. J Sleep Res (2000) 1.10

Effect of an inhaled atropinelike agent on normal airway function. J Appl Physiol Respir Environ Exerc Physiol (1979) 1.09

Hypoxic ventilatory response during sleep in normal premenopausal women. Am Rev Respir Dis (1982) 1.09

Nocturnal cough in patients with chronic bronchitis and emphysema. Am Rev Respir Dis (1984) 1.09

Continuous positive airway pressure improves vascular function in obstructive sleep apnoea/hypopnoea syndrome: a randomised controlled trial. Thorax (2008) 1.08

Asthma at night. Clin Chest Med (1985) 1.08

Sustained release choline theophyllinate in nocturnal asthma. Br Med J (Clin Res Ed) (1985) 1.07

Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society. Pneumologie (2010) 1.06

Do asthmatics suffer bronchoconstriction during rapid eye movement sleep? Br Med J (Clin Res Ed) (1986) 1.05

The effect of posture on airway caliber with the sleep-apnea/hypopnea syndrome. Am J Respir Crit Care Med (1995) 1.05